Age
Female sex
|
1.00 (0.97-1.04)
0.95 (0.40-2.27)
|
0.88
0.92
|
Diagnosis
GPA
MPA
|
1
1.83 (0.42-7.96)
|
0.42
|
ANCA pattern
Monophasic
Remitting
Persistent
Recurrent
|
1
1.93 (0.32-11.59)
3.45 (0.63-18.87)
4.26 (0.95-19.07)
|
0.47
0.15
0.06
|
Clinical features
Constitutional symptoms
Fever
Anemia
Microhaematuria
Alveolar haemorrhage
Pulmonary infiltrates
Pulmonary nodules
Mononeuritis multiplex
ENT involvement
Purpura
Arthritis
Ocular involvement
|
0.33 (0.14-0.78)
0.33 (0.13-0.86)
1.34 (0.18-10.05)
1.88 (0.44-8.07)
1.18 (0.48-2.94)
0.85 (0.20-3.72)
1.52 (0.20-11.51)
0.04 (0.00-8.13)
0.28 (0.04-2.12)
0.87 (0.11-6.67)
0.25 (0.08-0.76)
1.07 (0.25-4.62)
|
0.01
0.02
0.78
0.40
0.71
0.83
0.69
0.23
0.22
0.89
0.01
0.93
|
Treatment
Cyclophosphamide
Azathioprine
Methotrexate
Mycophenolic acid
Plasmapheresis
Rituximab
|
0.38 (0.10-1.47)
0.54 (0.21-1.41)
0.04 (0.00-141.05)
0.83 (0.30-2.29)
1.76 (0.50-6.24)
2.18 (0.86-5.52)
|
0.16
0.21
0.45
0.71
0.38
0.10
|